Phaedrus Life Science Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 18-05-2024
- Paid Up Capital ₹ 0.10 M
as on 18-05-2024
- Company Age 10 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 3.35 Cr
as on 18-05-2024
- Satisfied Charges ₹ 3.27 Cr
as on 18-05-2024
- Revenue 14.63%
(FY 2023)
- Profit -9.68%
(FY 2023)
- Ebitda 55.42%
(FY 2023)
- Net Worth 19.00%
(FY 2023)
- Total Assets 28.56%
(FY 2023)
About Phaedrus Life Science
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹3.35 Cr. The company has closed loans amounting to ₹3.27 Cr, as per Ministry of Corporate Affairs (MCA) records.
Snehalbhai Shah, Rekhaben Shah, and Malavkumar Shah serve as directors at the Company.
- CIN/LLPIN
U24230GJ2014PTC081003
- Company No.
081003
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Oct 2014
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Phaedrus Life Science Private Limited offer?
Phaedrus Life Science Private Limited offers a wide range of products and services, including TB, Tumor & Cancer Drugs, Anti Cancer Medicines, Vitamins & Supplements, Mineral Supplements.
Who are the key members and board of directors at Phaedrus Life Science?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Snehalbhai Shah  | Director | 09-Oct-2014 | Current |
| Rekhaben Shah | Director | 09-Oct-2014 | Current |
| Malavkumar Shah | Director | 05-Aug-2021 | Current |
Financial Performance of Phaedrus Life Science.
Phaedrus Life Science Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 14.63% increase. The company also saw a slight decrease in profitability, with a 9.68% decrease in profit. The company's net worth Soared by an impressive increase of 19%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Phaedrus Life Science?
Unlock access to Phaedrus Life Science's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Phaedrus Wellness Private LimitedActive 3 years 3 monthsSnehalbhai Shah and Malavkumar Shah are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 20 Jul 2021 | ₹1.00 Cr | Open |
Others Creation Date: 25 Nov 2020 | ₹3.50 M | Open |
Others Creation Date: 28 Oct 2016 | ₹7.50 M | Open |
How Many Employees Work at Phaedrus Life Science?
Unlock and access historical data on people associated with Phaedrus Life Science, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Phaedrus Life Science, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Phaedrus Life Science's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
